China Traditional Chinese Medicine Holdings Co. Limited (0570.HK)
HKD 2.31
(-0.86%)
HKD 2.31
(-0.86%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.16 Billion CNY | 2.33% |
| 2022 | 5.04 Billion CNY | -0.42% |
| 2021 | 5.06 Billion CNY | -3.01% |
| 2020 | 5.22 Billion CNY | -8.52% |
| 2019 | 5.7 Billion CNY | -6.96% |
| 2018 | 6.13 Billion CNY | 19.01% |
| 2017 | 5.15 Billion CNY | 31.81% |
| 2016 | 3.9 Billion CNY | 59.57% |
| 2015 | 2.45 Billion CNY | 109.04% |
| 2014 | 1.17 Billion CNY | -6.36% |
| 2013 | 1.25 Billion CNY | 204.2% |
| 2012 | 411.53 Million CNY | 49.31% |
| 2011 | 275.63 Million CNY | 195.92% |
| 2010 | 93.14 Million CNY | 25.88% |
| 2009 | 73.99 Million CNY | 361.99% |
| 2008 | 16.01 Million CNY | 0.0% |
| 2007 | - CNY | -100.0% |
| 2006 | 20.25 Million CNY | -95.43% |
| 2005 | 443.26 Million CNY | 0.39% |
| 2004 | 441.53 Million CNY | -9.07% |
| 2003 | 485.59 Million CNY | -14.06% |
| 2002 | 565.04 Million CNY | -26.4% |
| 2001 | 767.74 Million CNY | -3.94% |
| 2000 | 799.26 Million CNY | -14.48% |
| 1999 | 934.61 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 5.36 Billion CNY | 3.97% |
| 2024 Q2 | 5.36 Billion CNY | 2.2% |
| 2023 Q3 | 5.14 Billion CNY | -27.34% |
| 2023 Q4 | 5.16 Billion CNY | 0.36% |
| 2023 FY | 5.16 Billion CNY | 2.33% |
| 2023 Q2 | 7.07 Billion CNY | -2.75% |
| 2023 Q1 | 7.27 Billion CNY | 44.3% |
| 2022 Q1 | 7.39 Billion CNY | 46.12% |
| 2022 Q3 | 5.02 Billion CNY | -29.77% |
| 2022 Q4 | 5.04 Billion CNY | 0.33% |
| 2022 FY | 5.04 Billion CNY | -0.42% |
| 2022 Q2 | 7.15 Billion CNY | -3.28% |
| 2021 Q4 | 5.06 Billion CNY | 0.3% |
| 2021 Q1 | 6.52 Billion CNY | 25.01% |
| 2021 Q3 | 5.04 Billion CNY | -16.18% |
| 2021 Q2 | 6.02 Billion CNY | -7.71% |
| 2021 FY | 5.06 Billion CNY | -3.01% |
| 2020 Q2 | 7.01 Billion CNY | 0.17% |
| 2020 Q4 | 5.22 Billion CNY | 0.27% |
| 2020 FY | 5.22 Billion CNY | -8.52% |
| 2020 Q1 | 7 Billion CNY | 22.77% |
| 2020 Q3 | 5.2 Billion CNY | -25.81% |
| 2019 Q2 | 6.23 Billion CNY | 0.18% |
| 2019 Q4 | 5.7 Billion CNY | -1.1% |
| 2019 Q3 | 5.77 Billion CNY | -7.39% |
| 2019 Q1 | 6.21 Billion CNY | 1.4% |
| 2019 FY | 5.7 Billion CNY | -6.96% |
| 2018 Q4 | 6.13 Billion CNY | 0.0% |
| 2018 Q1 | 5.16 Billion CNY | 0.3% |
| 2018 FY | 6.13 Billion CNY | 19.01% |
| 2018 Q2 | 5.16 Billion CNY | 0.0% |
| 2018 Q3 | 6.13 Billion CNY | 18.66% |
| 2017 Q4 | 5.15 Billion CNY | 0.0% |
| 2017 Q1 | 5.45 Billion CNY | 39.59% |
| 2017 Q3 | 5.15 Billion CNY | -5.57% |
| 2017 FY | 5.15 Billion CNY | 31.81% |
| 2017 Q2 | 5.45 Billion CNY | 0.0% |
| 2016 Q3 | 3.9 Billion CNY | 42.72% |
| 2016 Q2 | 2.73 Billion CNY | 0.0% |
| 2016 Q1 | 2.73 Billion CNY | 11.81% |
| 2016 Q4 | 3.9 Billion CNY | 0.0% |
| 2016 FY | 3.9 Billion CNY | 59.57% |
| 2015 Q2 | 1.39 Billion CNY | 0.0% |
| 2015 Q4 | 2.45 Billion CNY | 0.0% |
| 2015 FY | 2.45 Billion CNY | 109.04% |
| 2015 Q3 | 2.45 Billion CNY | 75.28% |
| 2015 Q1 | 1.39 Billion CNY | 19.26% |
| 2014 Q2 | 1.14 Billion CNY | 0.0% |
| 2014 FY | 1.17 Billion CNY | -6.36% |
| 2014 Q4 | 1.17 Billion CNY | 0.0% |
| 2014 Q1 | 1.14 Billion CNY | -8.29% |
| 2014 Q3 | 1.17 Billion CNY | 2.1% |
| 2013 Q3 | 1.25 Billion CNY | 228.14% |
| 2013 FY | 1.25 Billion CNY | 204.2% |
| 2013 Q4 | 1.25 Billion CNY | 0.0% |
| 2013 Q2 | 381.51 Million CNY | -0.75% |
| 2013 Q1 | 384.38 Million CNY | -6.6% |
| 2012 Q3 | - CNY | -100.0% |
| 2012 FY | 411.53 Million CNY | 49.31% |
| 2012 Q2 | 407.3 Million CNY | 0.0% |
| 2012 Q4 | 411.53 Million CNY | 0.0% |
| 2011 Q4 | 275.63 Million CNY | 0.0% |
| 2011 Q2 | 200.94 Million CNY | 0.0% |
| 2011 FY | 275.63 Million CNY | 195.92% |
| 2010 Q4 | 93.14 Million CNY | 0.0% |
| 2010 FY | 93.14 Million CNY | 25.88% |
| 2010 Q2 | 46.11 Million CNY | 0.0% |
| 2009 Q4 | 73.99 Million CNY | 0.0% |
| 2009 FY | 73.99 Million CNY | 361.99% |
| 2009 Q2 | 93.89 Million CNY | 0.0% |
| 2008 FY | 16.01 Million CNY | 0.0% |
| 2008 Q4 | 16.01 Million CNY | 0.0% |
| 2007 FY | - CNY | -100.0% |
| 2006 FY | 20.25 Million CNY | -95.43% |
| 2005 FY | 443.26 Million CNY | 0.39% |
| 2004 FY | 441.53 Million CNY | -9.07% |
| 2003 FY | 485.59 Million CNY | -14.06% |
| 2002 FY | 565.04 Million CNY | -26.4% |
| 2001 FY | 767.74 Million CNY | -3.94% |
| 2000 FY | 799.26 Million CNY | -14.48% |
| 1999 FY | 934.61 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 6.8 Million HKD | -75672.904% |
| Grand Pharmaceutical Group Limited | 3.4 Billion HKD | -51.58% |
| Extrawell Pharmaceutical Holdings Limited | 120.41 Million HKD | -4185.47% |
| Wai Yuen Tong Medicine Holdings Limited | 460.94 Million HKD | -1019.459% |
| Qianhai Health Holdings Limited | 487 Thousand HKD | -1059475.77% |
| Lee's Pharmaceutical Holdings Limited | 204.14 Million HKD | -2427.743% |
| Essex Bio-Technology Limited | 294.02 Million HKD | -1655.015% |
| Tongfang Kontafarma Holdings Limited | 333.82 Million HKD | -1445.769% |
| PuraPharm Corporation Limited | 424.77 Million HKD | -1114.807% |
| SSY Group Limited | 3.37 Billion HKD | -52.934% |
| JBM (Healthcare) Limited | 133.4 Million HKD | -3767.963% |
| Jacobson Pharma Corporation Limited | 749.37 Million HKD | -588.588% |
| China Resources Pharmaceutical Group Limited | 85.84 Billion HKD | 93.989% |